Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Femarelle

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
To further investigate the interaction between vitamin D system and estrogen-mimetic compounds in the human vasculature we… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
2016
2016
OBJECTIVE To assess the effects of 2 months of treatment with Femarelle for climacteric syndrome in Taiwanese postmenopausal… Expand
2011
2011
Objective:The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on… Expand
2009
2009
Objective: The natural selective estrogen receptor modulator DT56a (Femarelle), derived from soybean, has been shown to relieve… Expand
2007
2007
A selective estrogen receptor modulator (SERM) is defined as a substance with dissimilar effects on different tissues: agonist in… Expand
2007
2007
  • I. Yoles, G. Lilling
  • European journal of obstetrics, gynecology, and…
  • 2007
  • Corpus ID: 39246553
The association between hormone replacement therapy (HRT) and breast cancer has been debated since the introduction of this… Expand
2005
2005
Objective  DT56a is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this study was to… Expand
2004
2004
OBJECTIVE In a previous study treatment with a daily standard dose of Femarelle (644 mg/day) resulted in a significant elevation… Expand
2003
2003
  • D. Somjen, I. Yoles
  • The Journal of Steroid Biochemistry and Molecular…
  • 2003
  • Corpus ID: 12806211
The novel natural product DT56a (Tofupill/Femarelle), derived from soybean, has been shown to relieve menopausal vasomotor… Expand
2003
2003
Objective To evaluate the efficacy of Tofupill/Femarelle (DT56a), a novel phyto-selective estrogen receptor modulator (SERM), in… Expand